These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23751260)

  • 1. Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda.
    Haberer JE; Kiwanuka J; Nansera D; Muzoora C; Hunt PW; So J; O'Donnell M; Siedner M; Martin JN; Bangsberg DR
    AIDS; 2013 Aug; 27(13):2166-8. PubMed ID: 23751260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda.
    Haberer JE; Musiimenta A; Atukunda EC; Musinguzi N; Wyatt MA; Ware NC; Bangsberg DR
    AIDS; 2016 May; 30(8):1295-300. PubMed ID: 26760452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Super learner analysis of real-time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non-differentiated care approaches for persons living with HIV in rural Uganda.
    Benitez AE; Musinguzi N; Bangsberg DR; Bwana MB; Muzoora C; Hunt PW; Martin JN; Haberer JE; Petersen ML
    J Int AIDS Soc; 2020 Mar; 23(3):e25467. PubMed ID: 32202067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting.
    Haberer JE; Kiwanuka J; Nansera D; Wilson IB; Bangsberg DR
    AIDS Behav; 2010 Dec; 14(6):1294-301. PubMed ID: 20532605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda.
    Ware NC; Pisarski EE; Tam M; Wyatt MA; Atukunda E; Musiimenta A; Bangsberg DR; Haberer JE
    AIDS; 2016 May; 30(8):1287-94. PubMed ID: 26807967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.
    Haberer JE; Musinguzi N; Boum Y; Siedner MJ; Mocello AR; Hunt PW; Martin JN; Bangsberg DR
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):386-92. PubMed ID: 26110445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supporting adherence to antiretroviral therapy with mobile phone reminders: results from a cohort in South India.
    Rodrigues R; Shet A; Antony J; Sidney K; Arumugam K; Krishnamurthy S; D'Souza G; DeCosta A
    PLoS One; 2012; 7(8):e40723. PubMed ID: 22952574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of short messaging service self-reported adherence with other adherence measures in a demonstration project of HIV preexposure prophylaxis in Kenya and Uganda.
    Musinguzi N; Muwonge T; Ngure K; Katabira E; Mugo N; Burns BFO; Baeten JM; Heffron R; Haberer JE;
    AIDS; 2018 Sep; 32(15):2237-2245. PubMed ID: 30005025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda.
    Musiime V; Kayiwa J; Kiconco M; Tamale W; Alima H; Mugerwa H; Abwola M; Apilli E; Ahimbisibwe F; Kizito H; Abongomera G; Namusoke A; Makabayi A; Kiweewa F; Ssali F; Kityo C; Colebunders R; Mugyenyi P
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1647-57. PubMed ID: 22545751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.
    Bagenda A; Barlow-Mosha L; Bagenda D; Sakwa R; Fowler MG; Musoke PM
    Ann Trop Paediatr; 2011; 31(3):235-45. PubMed ID: 21781419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.
    Franke MF; Kaigamba F; Socci AR; Hakizamungu M; Patel A; Bagiruwigize E; Niyigena P; Walker KD; Epino H; Binagwaho A; Mukherjee J; Farmer PE; Rich ML
    Clin Infect Dis; 2013 May; 56(9):1319-26. PubMed ID: 23249611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda.
    Weiser SD; Palar K; Frongillo EA; Tsai AC; Kumbakumba E; Depee S; Hunt PW; Ragland K; Martin J; Bangsberg DR
    AIDS; 2014 Jan; 28(1):115-20. PubMed ID: 23939234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily antiretroviral therapy in a cohort of HIV-infected children and adolescents.
    Jiménez-Montero B; Beceiro J; de José-Gómez MI; González-Tomé MI; Gurbindo-Gutierrez D; Martínez-Pérez J; Mellado-Peña MJ; Navarro-Gómez ML; Roa-Francia MA; Rojo-Conejo P; Saavedra-Lozano J; Jiménez de Ory S; Ramos-Amador JT;
    Pediatr Infect Dis J; 2014 Oct; 33(10):1052-4. PubMed ID: 24747153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South.
    Tucker JA; Simpson CA; Huang J; Roth DL; Stewart KE
    AIDS Patient Care STDS; 2013 May; 27(5):280-6. PubMed ID: 23651105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic Antiretroviral Therapy Adherence Monitors and Associated Interventions Improve Adolescent-Caregiver Relationships and Self-Efficacy Among Adolescents and Young Adults with HIV in Uganda.
    Adong J; Asiimwe S; Nansera D; Muyindike W; Tumuhairwe JB; Baijuka R; Tindimwebwa E; Garrison LE; Haberer JE
    AIDS Patient Care STDS; 2023 Oct; 37(10):489-494. PubMed ID: 37862075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence.
    Saberi P; Mayer K; Vittinghoff E; Naar-King S;
    AIDS Behav; 2015 Jan; 19(1):93-103. PubMed ID: 24879628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a mobile antiretroviral pharmacy and HIV care intervention on the continuum of HIV care in rural Uganda.
    Bajunirwe F; Ayebazibwe N; Mulogo E; Eng M; McGrath J; Kaawa-Mafigiri D; Mugyenyi P; Sethi AK
    AIDS Care; 2020 Sep; 32(9):1111-1115. PubMed ID: 32279527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda.
    Musinguzi N; Mocello RA; Boum Y; Hunt PW; Martin JN; Haberer JE; Bangsberg DR; Siedner MJ
    AIDS Behav; 2017 Jun; 21(6):1735-1740. PubMed ID: 27256394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa.
    Focà E; Odolini S; Sulis G; Calza S; Pietra V; Rodari P; Giorgetti PF; Noris A; Ouedraogo P; Simpore J; Pignatelli S; Castelli F
    BMC Infect Dis; 2014 Mar; 14():153. PubMed ID: 24656065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.
    Berg KM; Litwin AH; Li X; Heo M; Arnsten JH
    Clin Infect Dis; 2011 Nov; 53(9):936-43. PubMed ID: 21890753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.